OBJECTIVE: To investigate maternal and fetal folate and vitamin B12 concentrations in pregnancies affected by neural tube defects (NTD). DESIGN: Measurement of folate and vitamin B12 concentrations in amniotic fluid, fetal blood and maternal blood samples in midgestation. SUBJECTS: 32 women undergoing termination of pregnancy at 14-21 weeks gestation for social reasons (n = 24) or for fetuses with neural tube defects (n = 8). INTERVENTIONS: Fetoscopy before intra-amniotic injection of prostaglandins. RESULTS: In normal pregnancies there was a positive correlation between maternal and fetal serum folate, and the fetal serum and red blood cell folate concentrations were higher than the maternal. There were no differences in amniotic fluid, maternal blood or fetal blood folate concentrations between pregnancies with NTD and normal pregnancies. Although amniotic fluid vitamin B12 was lower in pregnancies with NTD, maternal serum vitamin B12 concentration was not reduced. CONCLUSION: In this small group of pregnancies with NTD at mid-gestation there is no evidence to suggest folate or vitamin B12 deficiency.
OBJECTIVE: To investigate maternal and fetal folate and vitamin B12 concentrations in pregnancies affected by neural tube defects (NTD). DESIGN: Measurement of folate and vitamin B12 concentrations in amniotic fluid, fetal blood and maternal blood samples in midgestation. SUBJECTS: 32 women undergoing termination of pregnancy at 14-21 weeks gestation for social reasons (n = 24) or for fetuses with neural tube defects (n = 8). INTERVENTIONS: Fetoscopy before intra-amniotic injection of prostaglandins. RESULTS: In normal pregnancies there was a positive correlation between maternal and fetal serum folate, and the fetal serum and red blood cell folate concentrations were higher than the maternal. There were no differences in amniotic fluid, maternal blood or fetal blood folate concentrations between pregnancies with NTD and normal pregnancies. Although amniotic fluid vitamin B12 was lower in pregnancies with NTD, maternal serum vitamin B12 concentration was not reduced. CONCLUSION: In this small group of pregnancies with NTD at mid-gestation there is no evidence to suggest folate or vitamin B12 deficiency.
Authors: F Pangilinan; A Mitchell; J VanderMeer; A M Molloy; J Troendle; M Conley; P N Kirke; M Sutton; J M Sequeira; E V Quadros; J M Scott; J L Mills; L C Brody Journal: J Med Genet Date: 2010-06-24 Impact factor: 6.318
Authors: Sonja Entringer; Elissa S Epel; Jue Lin; Elizabeth H Blackburn; Claudia Buss; Babak Shahbaba; Daniel L Gillen; Raman Venkataramanan; Hyagriv N Simhan; Pathik D Wadhwa Journal: Ann Nutr Metab Date: 2015-06-09 Impact factor: 3.374
Authors: Anne M Molloy; Peadar N Kirke; James F Troendle; Helen Burke; Marie Sutton; Lawrence C Brody; John M Scott; James L Mills Journal: Pediatrics Date: 2009-03 Impact factor: 7.124
Authors: Safdar Jawaid; James P Strainic; Jun Kim; Matthew R Ford; Lars Thrane; Ganga H Karunamuni; Megan M Sheehan; Amrin Chowdhury; Caitlyn A Gillespie; Andrew M Rollins; Michael W Jenkins; Michiko Watanabe; Stephanie M Ford Journal: Alcohol Clin Exp Res Date: 2021-01-02 Impact factor: 3.455